Day One Biopharmaceuticals, Inc. earnings per share and revenue

DAWN earnings per share for the last quarter are -0.63 USD whereas the estimation was -0.57 USD which accounts for -9.68% surprise. Företagets omsättning för samma period uppgår till 0.00 USD trots den uppskattade siffran 0.00 USD. Estimated earnings per share for the next quarter are -0.66 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of DAWN earnings per share and revenue dynamics.